Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design
Daisuke Kuroda, Kouhei Tsumoto
Journal of Pharmaceutical Sciences (2020) Vol. 109, Iss. 5, pp. 1631-1651
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 137
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies
Rahmad Akbar, Habib Bashour, Puneet Rawat, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 82
Applications of machine learning in antibody discovery, process development, manufacturing and formulation: Current trends, challenges, and opportunities
Thanh Tung Khuat, Robert Bassett, Ellen Otte, et al.
Computers & Chemical Engineering (2024) Vol. 182, pp. 108585-108585
Open Access | Times Cited: 25
Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics
Pin‐Kuang Lai, Austin Gallegos, Neil Mody, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 56
High concentration formulation developability approaches and considerations
Jonathan Zarzar, Tarik A. Khan, Maniraj Bhagawati, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Blueprint for antibody biologics developability
Carl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody
Jing Dai, Saeed Izadi, Jonathan Zarzar, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Toward Drug-Like Multispecific Antibodies by Design
Manali Sawant, Craig Streu, Lina Wu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7496-7496
Open Access | Times Cited: 52
Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations
Tobias M. Prass, Patrick Garidel, Michaela Blech, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 19, pp. 6129-6140
Open Access | Times Cited: 18
The Evolution of Commercial Antibody Formulations
Carl Mieczkowski
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 7, pp. 1801-1810
Open Access | Times Cited: 17
How can we discover developable antibody-based biotherapeutics?
Joschka Bauer, Nandhini Rajagopal, Priyanka Gupta, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 16
From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies
Stefania Carrara, Michael Ulitzka, Julius Grzeschik, et al.
International Journal of Pharmaceutics (2020) Vol. 594, pp. 120164-120164
Closed Access | Times Cited: 39
In silico prediction of post-translational modifications in therapeutic antibodies
Shabdita Vatsa
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Computational models for studying physical instabilities in high concentration biotherapeutic formulations
Marco A. Blanco
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Antibodies (2023) Vol. 12, Iss. 1, pp. 17-17
Open Access | Times Cited: 14
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools
Varun Dewaker, Vivek Kumar Morya, Yeon-Ju Kim, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances
Eugenio Gallo
Molecular Biotechnology (2024)
Closed Access | Times Cited: 4
A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles
Georgina Bethany Armstrong, Vidhi Shah, Paula Sanches, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2345-2357
Open Access | Times Cited: 4
A Practical Guide to Computational Tools for Engineering Biocatalytic Properties
Aitor Vega, Antoni Planas, Xevi Biarnés
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 980-980
Open Access
Large-scale application of free energy perturbation calculations for antibody design
Fangqiang Zhu, Feliza Bourguet, William F. Bennett, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
QTY code designed antibodies for aggregation prevention: A structural bioinformatic and computational study
Mengke Li, Yanze Wang, Fei Tao, et al.
Proteins Structure Function and Bioinformatics (2023) Vol. 92, Iss. 2, pp. 206-218
Open Access | Times Cited: 10
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
Paul J. Carter, Valerie Quarmby
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 898-913
Closed Access | Times Cited: 3
Engineering therapeutic antibodies for patient safety: tackling the immunogenicity problem
Michael Ulitzka, Stefania Carrara, Julius Grzeschik, et al.
Protein Engineering Design and Selection (2020) Vol. 33
Closed Access | Times Cited: 21
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
Smita Kumari, Rohan Gupta, Rashmi K. Ambasta, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188999-188999
Closed Access | Times Cited: 7
Delicate balance among thermal stability, binding affinity, and conformational space explored by single-domain VHH antibodies
Emina Ikeuchi, Daisuke Kuroda, Makoto Nakakido, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top